HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate)

phospholipids adsorbed on above cpd play the most important role in the nonthrombogenicity of the above cpd
Also Known As:
PMB30W; PMPC-b-PBMA copolymer; poly(2-methacryloyloxyethyl phosphorylcholine-co-butylmetacrylate); poly(MPC-co-BMA)
Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ishihara, Kazuhiko: 2 articles (01/2015 - 03/2011)
2. Konno, Tomohiro: 2 articles (01/2015 - 03/2011)
3. Matsumoto, Kazuhiro: 1 article (01/2015)
4. Tamura, Koetsu: 1 article (01/2015)
5. Miyajima, Akira: 1 article (01/2015)
6. Kikuchi, Eiji: 1 article (01/2015)
7. Oya, Mototsugu: 1 article (01/2015)
8. Seo, Ji-Hun: 1 article (03/2011)
9. Seo, Jeong-Sun: 1 article (03/2011)
10. Kim, Min Uk: 1 article (03/2011)

Related Diseases

1. Thrombosis (Thrombus)
2. Urinary Bladder Neoplasms (Bladder Cancer)

Related Drugs and Biologics

1. Paclitaxel (Taxol)
2. Polymers
3. 2-methacryloyloxyethyl phosphorylcholine
4. butyl methacrylate

Related Therapies and Procedures

1. Intravesical Administration